Apelin, a (neuro) vasoactive peptide, plays a prominent role in controlling water balance and cardiovascular functions. Apelin and its receptor co-localize with vasopressin in magnocellular vasopressinergic neurons. Apelin receptors (Apelin-Rs) are also expressed in the collecting ducts of the kidney, where vasopressin type 2 receptors are also present. Apelin and vasopressin interact at the brain and renal levels to maintain body fluid homeostasis by regulating diuresis in opposite directions. Apelin and angiotensin II have opposite effects on the regulation of blood pressure (BP). Angiotensin II, by binding to AT1 receptors present in VSMCs, induces intracellular calcium mobilization and vasoconstriction, while apelin, by binding to Apelin-R present on vascular endothelium, increases nitric oxide production and induces vasodilation. Apelin also plays a crucial role in the regulation of cardiac function. Apelin-deficient and Apelin-R-deficient mice develop progressive myocardial dysfunction with ageing and are susceptible to heart failure in response to pressure overload. Since the half-life of apelin is very short in vivo (in the minute range), several metabolically stable apelin analogs and non-peptidic Apelin-R agonists have been developed, with potential applications in diverse diseases. In this review, we highlight the interaction between apelin and vasopressin in the regulation of water balance and that between apelin and angiotensin II in the regulation of BP. Additionally, we underline the protective effects of apelin in cardiac function. Lastly, we discuss the beneficial effects of Apelin-R activation in different pathological states such as hyponatremia, hypertension, and heart failure.
Skip Nav Destination
Article navigation
Review Article|
January 29 2025
Metabolically stable apelin analogs: development and functional role in water balance and cardiovascular function
Pierre Couvineau
;
Pierre Couvineau
(Conceptualization, Writing - original draft, Writing - review & editing)
1Institut de Génomique Fonctionnelle, CNRS UMR5203, INSERM U1191, Montpellier University, Montpellier, France
Search for other works by this author on:
Catherine Llorens-Cortes
(Conceptualization, Supervision, Writing - original draft, Project administration, Writing - review & editing)
2Center for Interdisciplinary Research in Biology, College de France, Institut National de la Santé et de la Recherche Médicale, Paris, France
3Department of Medicines and Healthcare Technologies, CEA Paris-Saclay, Frédéric Joliot Institute for Life and Sciences, SIMoS, Gif-sur-Yvette, France
Correspondence: Catherine Llorens-Cortes ([email protected])
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
October 30 2024
Revision Received:
December 19 2024
Accepted:
December 23 2024
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2025 The Author(s); published by Portland Press Limited on behalf of the Biochemical Society.
2025
Clin Sci (Lond) (2025) 139 (02): 131–149.
Article history
Received:
October 30 2024
Revision Received:
December 19 2024
Accepted:
December 23 2024
Citation
Pierre Couvineau, Catherine Llorens-Cortes; Metabolically stable apelin analogs: development and functional role in water balance and cardiovascular function. Clin Sci (Lond) 28 January 2025; 139 (02): 131–149. doi: https://doi.org/10.1042/CS20240955
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
83
Views
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |